Chronic Depressive Personality Disorder Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: CD067DF7F34BEN
Market Monitor Global

Abstracts

Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of interest in daily activities, sadness, tiredness, trouble in concentrating and decision making, suicidal thoughts, and some others. Medication and psychotherapy are used for the management of chronic depressive personality disorder. Psychotherapy is preferred for children and adolescents instead of medication. But it also depend upon the severity of the chronic depressive personality disorder. Changing the lifestyle can also help in management of this disorder.

This report contains market size and forecasts of Chronic Depressive Personality Disorder Treatment in Global, including the following market information:

Global Chronic Depressive Personality Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chronic Depressive Personality Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Selective Serotonin Reuptake Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chronic Depressive Personality Disorder Treatment include Eli Lilly, Forest Laboratories, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Allergan and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Depressive Personality Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chronic Depressive Personality Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chronic Depressive Personality Disorder Treatment Market Segment Percentages, by Type, 2021 (%)

• Selective Serotonin Reuptake Inhibitors
• Tricyclic Antidepressants
• Norepinephrine Reuptake Inhibitors
• Others

Global Chronic Depressive Personality Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chronic Depressive Personality Disorder Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Chronic Depressive Personality Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chronic Depressive Personality Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chronic Depressive Personality Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chronic Depressive Personality Disorder Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Forest Laboratories
• GlaxoSmithKline
• Merck Sharp & Dohme
• Pfizer
• Allergan
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Chronic Depressive Personality Disorder Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Chronic Depressive Personality Disorder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CHRONIC DEPRESSIVE PERSONALITY DISORDER TREATMENT OVERALL MARKET SIZE

2.1 Global Chronic Depressive Personality Disorder Treatment Market Size: 2021 VS 2028
2.2 Global Chronic Depressive Personality Disorder Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Chronic Depressive Personality Disorder Treatment Players in Global Market
3.2 Top Global Chronic Depressive Personality Disorder Treatment Companies Ranked by Revenue
3.3 Global Chronic Depressive Personality Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Chronic Depressive Personality Disorder Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Depressive Personality Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Depressive Personality Disorder Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Chronic Depressive Personality Disorder Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Chronic Depressive Personality Disorder Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Chronic Depressive Personality Disorder Treatment Market Size Markets, 2021 & 2028
  4.1.2 Selective Serotonin Reuptake Inhibitors
  4.1.3 Tricyclic Antidepressants
  4.1.4 Norepinephrine Reuptake Inhibitors
  4.1.5 Others
4.2 By Type - Global Chronic Depressive Personality Disorder Treatment Revenue & Forecasts
  4.2.1 By Type - Global Chronic Depressive Personality Disorder Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Chronic Depressive Personality Disorder Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Chronic Depressive Personality Disorder Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Chronic Depressive Personality Disorder Treatment Revenue & Forecasts
  5.2.1 By Application - Global Chronic Depressive Personality Disorder Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Chronic Depressive Personality Disorder Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Chronic Depressive Personality Disorder Treatment Market Size, 2021 & 2028
6.2 By Region - Global Chronic Depressive Personality Disorder Treatment Revenue & Forecasts
  6.2.1 By Region - Global Chronic Depressive Personality Disorder Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Chronic Depressive Personality Disorder Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Chronic Depressive Personality Disorder Treatment Revenue, 2017-2028
  6.3.2 US Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.3.3 Canada Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.3.4 Mexico Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Chronic Depressive Personality Disorder Treatment Revenue, 2017-2028
  6.4.2 Germany Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.4.3 France Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.4.4 U.K. Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.4.5 Italy Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.4.6 Russia Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.4.8 Benelux Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Chronic Depressive Personality Disorder Treatment Revenue, 2017-2028
  6.5.2 China Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.5.3 Japan Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.5.4 South Korea Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.5.6 India Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Chronic Depressive Personality Disorder Treatment Revenue, 2017-2028
  6.6.2 Brazil Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.6.3 Argentina Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Chronic Depressive Personality Disorder Treatment Revenue, 2017-2028
  6.7.2 Turkey Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.7.3 Israel Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028
  6.7.5 UAE Chronic Depressive Personality Disorder Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.1.4 Eli Lilly Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Forest Laboratories
  7.2.1 Forest Laboratories Corporate Summary
  7.2.2 Forest Laboratories Business Overview
  7.2.3 Forest Laboratories Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.2.4 Forest Laboratories Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.2.5 Forest Laboratories Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.3.4 GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Merck Sharp & Dohme
  7.4.1 Merck Sharp & Dohme Corporate Summary
  7.4.2 Merck Sharp & Dohme Business Overview
  7.4.3 Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.4.4 Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck Sharp & Dohme Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.5.4 Pfizer Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Allergan
  7.6.1 Allergan Corporate Summary
  7.6.2 Allergan Business Overview
  7.6.3 Allergan Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.6.4 Allergan Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.6.5 Allergan Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Chronic Depressive Personality Disorder Treatment Major Product Offerings
  7.7.4 Novartis Chronic Depressive Personality Disorder Treatment Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Chronic Depressive Personality Disorder Treatment Market Opportunities & Trends in Global Market
Table 2. Chronic Depressive Personality Disorder Treatment Market Drivers in Global Market
Table 3. Chronic Depressive Personality Disorder Treatment Market Restraints in Global Market
Table 4. Key Players of Chronic Depressive Personality Disorder Treatment in Global Market
Table 5. Top Chronic Depressive Personality Disorder Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Depressive Personality Disorder Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Depressive Personality Disorder Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Depressive Personality Disorder Treatment Product Type
Table 9. List of Global Tier 1 Chronic Depressive Personality Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Depressive Personality Disorder Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Depressive Personality Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Depressive Personality Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Depressive Personality Disorder Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Depressive Personality Disorder Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Chronic Depressive Personality Disorder Treatment Product Offerings
Table 32. Eli Lilly Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Forest Laboratories Corporate Summary
Table 34. Forest Laboratories Chronic Depressive Personality Disorder Treatment Product Offerings
Table 35. Forest Laboratories Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Product Offerings
Table 38. GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck Sharp & Dohme Corporate Summary
Table 40. Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Product Offerings
Table 41. Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Chronic Depressive Personality Disorder Treatment Product Offerings
Table 44. Pfizer Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Allergan Corporate Summary
Table 46. Allergan Chronic Depressive Personality Disorder Treatment Product Offerings
Table 47. Allergan Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Chronic Depressive Personality Disorder Treatment Product Offerings
Table 50. Novartis Chronic Depressive Personality Disorder Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Depressive Personality Disorder Treatment Segment by Type in 2021
Figure 2. Chronic Depressive Personality Disorder Treatment Segment by Application in 2021
Figure 3. Global Chronic Depressive Personality Disorder Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Depressive Personality Disorder Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Depressive Personality Disorder Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Depressive Personality Disorder Treatment Revenue in 2021
Figure 8. By Type - Global Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 12. US Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 24. China Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Depressive Personality Disorder Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Depressive Personality Disorder Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Forest Laboratories Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Allergan Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Chronic Depressive Personality Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)